Kyle Jenne
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Kyle Jenne is currently Chief Global Product Strategy Officer & EVP at Ionis Pharmaceuticals, Inc. since 2024.
Former roles include Chief Executive Officer & Director at Elsie Biotechnologies Inc., Chief Commercial Officer & Executive VP at Ionis Pharmaceuticals, Inc., and Senior Vice President-US Commercial at Akcea Therapeutics, Inc. from 2017 to 2019.
Education includes undergraduate studies at Arizona State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-04-2026 | 23.713 ( 0,01% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29-02-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Algemeen Directeur | - |
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akcea Therapeutics, Inc.
Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Elsie Biotechnologies Inc.
Elsie Biotechnologies Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oligonucleotide therapeutics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau